These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 18711750)
1. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one inhibits neurite outgrowth and causes neurite retraction in PC12 cells independently of soluble guanylyl cyclase. Lee HG; Kim SY; Kim du S; Seo SR; Lee SI; Shin DM; De Smet P; Seo JT J Neurosci Res; 2009 Jan; 87(1):269-77. PubMed ID: 18711750 [TBL] [Abstract][Full Text] [Related]
2. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542 [TBL] [Abstract][Full Text] [Related]
3. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Schrammel A; Behrends S; Schmidt K; Koesling D; Mayer B Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo. Sammut S; Threlfell S; West AR Neuropharmacology; 2010 Mar; 58(3):624-31. PubMed ID: 19969007 [TBL] [Abstract][Full Text] [Related]
5. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Hussain AS; Marks GS; Brien JF; Nakatsu K Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020 [TBL] [Abstract][Full Text] [Related]
6. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells. Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells. Bellamy TC; Garthwaite J Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273 [TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons. Doucet MV; O'Toole E; Connor T; Harkin A Neuroscience; 2015 Aug; 301():421-38. PubMed ID: 26071957 [TBL] [Abstract][Full Text] [Related]
9. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one induces cell cycle arrest and apoptosis in HeLa cells by preventing microtubule polymerization. Kim SY; An JM; Lee HG; Du SK; Cheong CU; Seo JT Biochem Biophys Res Commun; 2011 May; 408(2):287-92. PubMed ID: 21501588 [TBL] [Abstract][Full Text] [Related]
10. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Sobey CG; Faraci FM Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205 [TBL] [Abstract][Full Text] [Related]
11. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental parkinsonism. Tseng KY; Caballero A; Dec A; Cass DK; Simak N; Sunu E; Park MJ; Blume SR; Sammut S; Park DJ; West AR PLoS One; 2011; 6(11):e27187. PubMed ID: 22073284 [TBL] [Abstract][Full Text] [Related]
13. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes. Wegener JW; Closs EI; Förstermann U; Nawrath H Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560 [TBL] [Abstract][Full Text] [Related]
14. The soluble guanylyl cyclase inhibitor ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, dose-dependently reduces the threshold for isoflurane anesthesia in rats. Cechova S; Pajewski TN Anesth Analg; 2004 Sep; 99(3):752-757. PubMed ID: 15333406 [TBL] [Abstract][Full Text] [Related]
16. Fundamental role of nitric oxide in neuritogenesis of PC12h cells. Yamazaki M; Chiba K; Mohri T Br J Pharmacol; 2005 Nov; 146(5):662-9. PubMed ID: 16113690 [TBL] [Abstract][Full Text] [Related]
17. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats. Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652 [TBL] [Abstract][Full Text] [Related]
18. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658 [TBL] [Abstract][Full Text] [Related]
19. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries. Pearce WJ; Williams JM; White CR; Lincoln TM J Appl Physiol (1985); 2009 Jul; 107(1):192-9. PubMed ID: 19407253 [TBL] [Abstract][Full Text] [Related]
20. Cyclic GMP-dependent neurite outgrowth by genipin and nerve growth factor in PC12h cells. Yamazaki M; Chiba K; Mohri T; Hatanaka H Eur J Pharmacol; 2004 Mar; 488(1-3):35-43. PubMed ID: 15044033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]